- PROFESSOR Medicine, Hematology and Medical Oncology
- PROFESSOR Oncological Sciences
- PROFESSOR Preventive Medicine
MD, University of Turin
Internship, University Hospital Turin
MPH, Columbia University
- Cancer Epidemiology
- Cancer prevention
Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Associate Director for Population Sciences of The Tisch Cancer Institute and Chief of the Division of Cancer Prevention and Control of the Department of Oncological Sciences. He is also the Bluhdorn Professor of International Community Medicine.
Dr. Boffetta is Adjunct Professor at the Harvard School of Public Health (Boston, MA), Vanderbilt University (Nashville, TN), and the Catholic University of Rome (Italy). He is also Affiliate Member of the R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa (Ottawa, Canada), and Senior Fellow of the Hellenic Health Foundation (Athens, Greece).
Read a press release on Dr. Boffetta's study of the relationship between high consumption of fruits and vegetables and risk of cancer.
Watch a video from BMJ.com on tea drinking habits and oesophageal cancer in Iran.
Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD. Association between body-mass index and risk of death in more than 1 million Asians. The New England journal of medicine 2011 Feb; 364(8).
Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, Seminara D, Goode EL, Yoo KY, Demers P, Gallagher R, Prentice R, Yasui Y, O'Doherty K, Petersen GM, Ulrich CM, Csizmadi I, Amankwah EK, Brockton NT, Kopciuk K, McGregor SE, Kelemen LE. Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer causes & control : CCC 2011 Mar; 22(3).
Boffetta P, Jayaprakash V, Yang P, Asomaning K, Muscat JE, Schwartz AG, Zhang ZF, Le Marchand L, Cote ML, Stoddard SM, Morgenstern H, Hung RJ, Christiani DC. Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO). Cancer causes & control : CCC 2011 Jan; 22(1).
Boffetta P, Et Al . Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). . J Natl Cancer Inst 2010; 102: 529-537.
Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low- and medium-income countries. . Ann Oncol. ; 2010(March 15).
McCormack V, A, Dahm C, Overvad K, Olsen A, Tjonneland A, Kaaks R, Boeing H, Manjer J, Almquist M, Hallmans G, Johansson I, Chirlaque M, Barricarte A, Dorronsoro M, Rodriguez L, Redondo M , Khaw K, Wareham N, Allen N , Key T, Riboli E, Boffetta P. Cigar and pipe smoking and cancer risk in the european prospective investigation into cancer and nutrition. . Int J Cancer. 2010 Feb 16;.
Boffetta P. Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis 2010 Jan; 31(1).
Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. . BMJ; 2009(339): b3060.
Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A , Konobeevskaya I, Igitov V V, Terechova T, Boffetta P, Peto R. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths.. Lancet 2009 2201; 373.
Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet C, Brennan P, Møller H, Saidi F, Dawsey S, Malekzadeh R, Boffetta P. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. . BMJ 2009;(338): b929.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Boffetta during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- ENVIRON Global; Eni S.p.A.; European Medicines Agency (EMA); Exponent; ILVA Steelworks; International Prevention Research Institute (iPRI); Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Monsanto Company; Takeda Pharmaceutical Company Limited
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
17 East 102 Street Floor 4th Floor Room 4-110
New York, NY 10029